Spinal Surgery after Bilateral Subthalamic Stimulation for Patients with Parkinson's Disease: A Retrospective Outcome Analysis of Pain and Functional Control by Umakoshi, Michiari et al.
607
doi: 10.2176/nmc.oa.2021-0094ORIGINAL ARTICLE
Spinal Surgery after Bilateral Subthalamic Stimulation 
for Patients with Parkinson’s Disease: A Retrospective 
Outcome Analysis of Pain and Functional Control
Michiari UMAKOSHI,1 Takao YASUHARA,1 Jun MORIMOTO,1 Satoshi MURAI,1 
Tatsuya SASAKI,1 Masahiro KAMEDA,1 Kyohei KIN,1 Yasuyuki MIYOSHI,2  
and Isao DATE1
1Department of Neurological Surgery, Okayama University Graduate School of Medicine, 
Dentistry, and Pharmaceutical Sciences, Okayama, Okayama, Japan
2Department of Neurosurgery, Kawasaki Medical School General Medical Center, Okayama, 
Okayama, Japan
Abstract
Parkinson’s disease (PD) patients often suffer from spinal diseases requiring surgeries, although 
the risk of complications is high. There are few reports on outcomes after spinal surgery for PD 
patients with deep brain stimulation (DBS). The objective of this study was to explore the data on 
spinal surgery for PD patients with precedent DBS. We evaluated 24 consecutive PD patients with 
28 spinal surgeries from 2007 to 2017 who received at least a 2-year follow-up. The characteris-
tics and outcomes of PD patients after spinal surgery were compared to those of 156 non-PD 
patients with degenerative spinal diseases treated in 2013–2017. Then, the characteristics, out-
comes, and spinal alignment of PD patients receiving DBS were analyzed in degenerative spinal/
lumbar diseases. The mean age at the time of spinal surgery was 68 years. The Hoehn and Yahr 
score regarding PD was stage 1 for 8 patients, stage 2 for 2 patients, stage 3 for 8 patients, stage 4 
for 10 patients, and stage 5 for 0 patient. The median preoperative L-DOPA equivalent daily dose 
was 410 mg. Thirteen patients (46%) received precedent subthalamic nucleus (STN) DBS. Lum-
bar lesions with pain were common, and operation and anesthesia times were long in PD patients. 
Pain and functional improvement of PD patients persisted for 2 years after surgery with a higher 
complication rate than for non-PD patients. PD patients with STN DBS maintained better lumbar 
lordosis for 2 years after spinal surgery. STN DBS significantly maintained spinal alignment with 
subsequent pain and functional amelioration 2 years after surgery. The outcomes of spinal sur-
gery for PD patients might be favorably affected by thorough treatment for PD including DBS.
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Introduction
Parkinson’s disease (PD) is a neurodegenerative 
disorder related to the dysfunction of nigrostriatal 
dopaminergic neurons. PD is now the second most 
common degenerative neurological disorder in the 
elderly population.1) PD patients usually experience 
exacerbated clinical symptoms, including reduced 
mobility, shuffling gait, rigidity, balance disorder, 
abnormal posture, or pain.2,3) PD patients are also 
known to suffer from comorbidities such as degen-
erative disorders of the whole-body joints and 
spine.4,5) These degenerative conditions can further 
impair the quality of life of such patients.4) Several 
studies have reported poor outcomes of PD patients 
who have undergone spinal surgery and increased 
complications, implant failures, or revision surgeries, 
yet possible contributing or predictive factors for 
the postoperative outcomes of PD patients have not 
been well explored. On the other hand, neuromod-
ulation including deep brain stimulation (DBS) 
might potentially improve abnormal posture and 
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spinal deformities associated with PD.6,7) DBS has 
been an established treatment modality for PD 
patients to improve their symptoms, including 
rigidity and tremors. However, there are few previous 
reports focusing on whether DBS can affect the 
postoperative outcomes of spinal surgery in PD 
patients.
In this study, we first conducted a cohort study 
to compare the characteristics and outcomes of 
spinal surgeries for PD and non-PD patients. 
Second, the characteristics, outcomes, and spinal 
alignment of PD patients with precedent subtha-
lamic nucleus (STN) DBS were evaluated and 
compared to those of patients without DBS. Third, 
to minimize the heterogeneity of the patients, 
patients with degenerative lumbar diseases were 
evaluated.
Methods
This is a retrospective study approved by the Insti-
tutional Review Board of Okayama University 
Hospital (IRB#1904-034).
Study 1: Characteristics and outcomes of PD 
 patients after spinal surgery
We first conducted a case–control study comparing 
the PD and non-PD patients in terms of degener-
ative spinal diseases to describe the characteris-
tics and outcomes of PD patients. We included 
24 consecutive PD patients with 28 spinal surgeries 
from 2007 to 2017 and 156 consecutive non-PD 
patients with spinal surgeries from 2013 to 2017. 
All the patients included in this study had symp-
tomatic degenerative spinal disease or vertebral 
fracture with at least a 2-year follow-up after 
surgery. The characteristics of patients evaluated 
in this study were following: 1) Background: age; 
gender; previous history of hypertension or diabetes; 
body mass index (BMI); history of vertebral frac-
ture, hip joint, or spinal surgery; administration 
of parathyroid hormone (PTH); previous neuro-
modulation; the duration after the diagnosis of 
PD; PD severity (Hoehn and Yahr scale); the 
preoperative L-DOPA equivalent daily dose for 
PD patients; location of the lesion; and preoper-
ative symptoms; 2) operative information: types 
of surgery, operation and anesthesia times, and 
blood loss; 3) outcomes: The Japanese Orthopedic 
Association (JOA) score, the numerical rating scale 
(NRS) score, the duration of hospitalization, and 
complications. All of these data were collected 
and analyzed, and we then compared the param-
eters in the 3 categories for PD and non-PD 
patients.
Study 2: Characteristics and outcomes of PD 
 patients receiving precedent STN DBS after spinal 
surgery
Second, we also compared the parameters in the 
3 categories described earlier between PD patients 
with and without precedent STN DBS (n = 13 and 
15). In addition to the analyses described earlier, 
spinal alignment was measured and evaluated before 
and at 2 years after surgery. The measured param-
eters were as follows: C7 sagittal vertical axis 
(C7SVA), Cobb angle, thoracic kyphosis (TK; T5-T12), 
lumbar lordosis (LL; T12-L5), pelvic incidence (PI), 
PI-LL, pelvic tilt (PT), and sacral slope (SS).
Study 3: The subgroup analyses of patients with 
lumbar degenerative diseases
To minimize the heterogeneity of patients, we 
then conducted subgroup analyses of lumbar degen-
erative disease patients like study 1 and 2 as referred 
to earlier. We included 19 consecutive PD patients 
(10 patients with STN DBS and 9 patients without 
DBS) who underwent lumbar surgery between 2007 
and 2017, and 55 consecutive non-PD patients who 
underwent lumbar surgery.
Definition of the outcome measurements
For the neurological and neuroradiological eval-
uations, the blinded examiner collected the data. 
In terms of neurological investigations, the JOA 
improvement rate was defined as (postoperative 
JOA score − preoperative JOA score)/(17 − preop-
erative JOA score) × 100 (%) for cervical lesions 
and (postoperative JOA score − preoperative JOA 
score)/(29 − preoperative JOA score) × 100 (%) for 
thoracic and lumbar lesions. We also defined the 
JOA improvement rate at 2 years as (JOA score at 
2  years  − preoperative JOA score)/(17 − preopera-
tive JOA score) × 100 (%) for cervical lesions and 
the JOA improvement rate at 2 years as (JOA score 
at 2 years − preoperative JOA score)/(29 − preop-
erative JOA score) × 100 (%) for thoracic and lumbar 
lesions. Similarly, the NRS reduction ratio was 
defined as (postoperative NRS − preoperative NRS)/
preoperative NRS × 100 (%). The NRS reduction 
ratio at 2 years was also defined as (NRS at 2 years 
− preoperative NRS)/preoperative NRS × 100 (%). 
Categorical outcomes were utilized, and subjects 
were grouped based on percentage of functional 
recovery and pain relief: functional recovery in 
JOA and pain reduction in NRS of less than 30% 
and 50%, equal to or greater than 30% and 50% 
and less than 50% and 70%, and equal to or greater 
than 50% and 70%.8) NRS and JOA scores were 
evaluated before, 3 months after, and 2 years after 
the surgery. In neuroradiological investigations, all 
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the parameters for spinal alignment were calculated 
using the OsiriX DICOM viewer (Pixmeo Sàrl, 
Bernex, Switzerland). The diagnosis of postopera-
tive implant failure, including pedicle screw loos-
ening, rod fracture, cage migration, and postoper-
ative fracture, were conducted by the blinded 
examiner. If the results were inconclusive, the 
diagnosis of each case was discussed with radiol-
ogists. Postoperative complications were defined 
as infection, delirium, fall, and other complications. 
Implant failure and reoperation were also evaluated.
Statistical analyses
Descriptive statistics were performed using mean 
with standard deviation or median with interquar-
tile range for continuous variables, as appropriate, 
and number with percentage for categorical variables. 
The cutoff points for JOA and NRS improvement 
rates were calculated using a receiver operating 
characteristic curve. The groups were compared 
using Student’s t-test or Wilcoxon rank-sum test for 
continuous variables, and Pearson’s chi-squared test 
or Fisher’s exact test for categorical variables, as 
appropriate. We were unable to conduct multivari-
able analysis because of the small sample size. We 
used JMP 14 software (SAS Institute, Cary, NC, 
USA), and the statistical difference was set as 
p <0.05.
Results
Study 1: Characteristics and outcomes of 
PD patients after spinal surgery
Patient characteristics: PD vs. non-PD groups
Patient characteristics are summarized in Table 1. 
There were significant differences between the PD 
(n = 28) and non-PD (n = 156) groups in terms of 
female sex (54% vs. 29%, p = 0.01), history of hyper-
tension (29% vs. 58%, p = 0.004), history of verte-
bral fracture (21% vs. 3%, p = 0.002), PTH (14% 
vs. 2%, p = 0.011), cervical lesion (32% vs. 61%, 
p = 0.0047), lumbar lesion (68% vs. 35%, p = 0.0012), 
the presence of local pain (64% vs. 33%, p = 0.002), 
motor disability (57% vs. 87%, p <0.001), and 
numbness (61% vs. 89%, p <0.001). On the other 
hand, no significant differences were observed in 
terms of the mean age at surgery, history of diabetes, 
mean BMI, and history of hip joint surgery, spinal 
surgery, thoracic lesion, or limb pain. For the PD 
group, the mean duration after the diagnosis of PD 
at the initial surgery was 10 years. The Hoehn and 
Yahr score was stage 1 for 8 cases (29%), stage 2 
for 2 (7%), stage 3 for 8 (29%), stage 4 for 10 (36%), 
and stage 5 for 0. The median preoperative L-DOPA 
equivalent daily dose was 410 mg (range 200–660 mg). 
Thirteen cases (46%) had undergone previous STN 
DBS and 2 (7%) had undergone spinal cord stim-
ulation (SCS). All PD patients with DBS received 
bilateral STN DBS in this study. The median dura-
tion between precedent STN DBS and spinal surgery 
was 48 months (4–137 months). Two patients received 
SCS because of lumbago after DBS. One received 
SCS 26 months before spinal surgery and the other 
20 months after spinal surgery with subsequent 
mild–moderate reduction of lumbago. Both patients 
with SCS had relatively good spinal alignment and 
SCS did not affect the spinal alignment.
Operative information: PD vs. non-PD groups
Operative characteristics are summarized in supple-
mentary Table 1 (All supplementary tables are avail-
able Online). There were significant differences 
between the PD and non-PD groups in terms of 
laminoplasty (32% vs. 54%, p = 0.034), the mean 
duration of anesthesia (390 vs. 330 min, p = 0.035), 
the mean duration of operation (310 vs. 230 min, p = 0.0023), 
and median blood loss (120 vs. 100 ml, p = 0.03). 
There were no significant differences between the 
groups in terms of decompression, fusion, or multi-
level surgery. In the PD group, 2 and 1 patients 
underwent 1 and 2 additional surgeries, respectively. 
All the cases with additional surgeries had undergone 
lumbar surgery as the initial surgery. The first patient 
underwent decompression and fusion (2-level poste-
rior lumbar interbody fusion [PLIF] for L3/4, 4/5) 
for restenosis at 6 years after the initial surgery (L4/5 
PLIF). The second patient underwent long fusion 
with vertebral column resection for a vertebral frac-
ture after a fall at 2 years after the initial surgery. 
The third patient required 2 additional operations 
including spinal fusion in 3 years.
Outcomes: PD vs. non-PD groups
The functional amelioration and pain reduction 
were recognized in all the patients involved in this 
study, although the degree of symptom improvement 
varied by case. Comparative data for postoperative 
outcomes are summarized in Table 2. With respect 
to JOA score, the improvement rate was preserved 
at 2 years after the surgery (PD group: 48% vs. 
non-PD group: 40%) as well as at 3 months (PD 
group: 47% vs. non-PD group: 40%) with no signif-
icant difference between the 2 groups. Regarding 
NRS score, significant differences were observed in 
median NRS before and at 2 years after surgery (PD 
group: 8 and 3 vs. non-PD group: 6 and 2, p = 0.001 
and p = 0.083, respectively). The NRS reduction 
rate of the PD group (71%, p = 0.051) was nearly 
significantly larger than that of the non-PD group 
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(50%) after surgery. The mean duration of the 
hospitalization showed no significant difference 
between the groups. Regarding complications, the 
overall complication rate was significantly higher 
in the PD group (36%, p <0.001) than in the non-PD 
group (4%). The PD group showed a significantly 
higher rate of infection (11% vs. 1%, p = 0.01), 
delirium (25% vs. 2%, p <0.001), fall (7% vs. 0%, 
p = 0.022), implant failure (7% vs. 0%, p = 0.022), 
and reoperation (14% vs. 4%, p = 0.047). There 
was no case with complications requiring reopera-
tion in 6 months.
Study 2: Characteristics, outcomes, and spinal 
alignment of PD patients receiving DBS after spinal 
surgery
Patient characteristics: DBS vs. non-DBS groups
Characteristics of PD patients with (n = 13) and 
without precedent STN DBS (n = 15) are presented 
Table 1 Characteristics of the PD and non-PD groups
Factor PD group (n = 28) Non-PD group (n = 156) p value
Age at spinal surgery, years 68.3 ± 7.7 68.5 ± 10.2 0.90
Age at spinal surgery over 75 (%) 6 (21.4) 44 (28.2) 0.46
Female sex (%) 15 (53.6) 45 (28.8) 0.01
Comorbidities
HT (%) 8 (28.6) 91 (58.3) 0.004
DM (%) 9 (32.1) 39 (25.0) 0.43
BMI, kg/m2 24.6 ± 3.1 24.6 ± 3.6 0.98
BMI ≥25 (%) 13 (46.4) 69 (44.2) 0.83
History of vertebral fracture (%) 6 (21.4) 5 (3.2) 0.002
History of hip joint surgery (%) 1 (3.6) 0 (0.0) 0.15
History of spinal surgery (%) 9 (32.1) 34 (21.8) 0.23
PTH administration (%) 4 (14.3) 3 (1.9) 0.011
History of SCS (%) 2 (7.1) 0 (0.0) 1
History of DBS (%) 13 (46.4) 0 (0.0) 1
PD
Duration of PD, years 10.4 ± 7.5 -
Hoehn and Yahr score (%)
 1 8 (28.6) -
 2 2 (7.1) -
 3 8 (28.6) -
 4 10 (35.7) -
 Over 3 18 (64.3) -
Preoperative L-DOPA dose, mg 410 (IQR: 200–656)
Location
Cervical (%) 9 (32.1) 95 (60.9) 0.0047
Thoracic (%) 0 (0.0) 12 (7.7) 0.22
Lumbar (%) 19 (67.9) 55 (35.3) 0.0012
Symptoms
Limb pain (%) 17 (60.7) 95 (60.9) 0.99
Local pain (%) 18 (64.3) 52 (33.3) 0.002
Motor disability (%) 16 (57.1) 135 (86.5) <0.001
Numbness (%) 17 (60.7) 138 (88.5) <0.001
BMI: body-mass index, DBS: deep brain stimulation, DM: diabetes mellitus, HT: hypertension, IQR: interquartile range, local 
pain: lumbago and neck pain, PD: Parkinson’s disease, PTH: parathyroid hormone, SCS: spinal cord stimulation.
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in Table 3. The DBS group showed a significantly 
younger mean age at the surgery (65 vs. 72 years, 
p = 0.011) and a higher percentage of PTH admin-
istration (31% vs. 0%, p = 0.035). The DBS group 
also showed a significantly longer mean duration of 
PD (14 vs. 8 years, p = 0.037). Additionally, the 
DBS group showed a significantly higher percentage 
of patients with Hoehn and Yahr scores over 3 (100% 
vs. 33%, p <0.001) and a higher preoperative L-DOPA 
equivalent daily dose (640 vs. 200 mg, p <0.001).
Table 2 Outcomes of the PD and non-PD groups
Factor PD group (n = 28) Non-PD group (n = 156) p value
JOA
JOA before surgery (IQR) 8 (5–11) 9 (7–11) 0.23
JOA after surgery (IQR) 19.5 (10–22.3) 13 (11–21) 0.19
JOA at 2 years (IQR) 18 (10–22.8) 13 (10–22) 0.61
JOA improvement rate after surgery, % (IQR) 46.5 (33.3–67.2) 40 (25–57.1) 0.17
 <30 after surgery (%) 4 (14.3) 51 (32.7) 0.075
 30–50 after surgery (%) 12 (42.9) 40 (25.6)
 50≤ after surgery (%) 12 (42.9) 65 (41.7)
JOA improvement rate at 2 years, % (IQR) 48.1 (22.9–74) 40 (20.6–71) 0.74
 <30 at 2 years (%) 7 (26.9) 57 (37.3) 0.55
 30–50 at 2 years (%) 6 (23.1) 26 (17.0)
 50≤ at 2 years (%) 13 (50.0) 70 (45.8)
NRS
NRS before surgery (IQR) 8 (5.8–10) 6 (4–8) 0.001
NRS after surgery (IQR) 2 (2–3.3) 3 (2–3) 0.11
NRS at 2 years (IQR) 3 (2–4) 2 (1–3) 0.083
NRS reduction rate after surgery, % (IQR) 71.4 (15–80) 50 (25–63.6) 0.051
 <50 after surgery (%) 10 (35.7) 73 (46.8) <0.001
 50–70 after surgery (%) 2 (7.1) 53 (34.0)
 70≤ after surgery (%) 16 (57.1) 30 (19.2)
NRS reduction rate at 2 years, % (IQR) 52.7 (0–80) 57.1 (33.3–77.8) 0.54
 <50 at 2 years (%) 13 (50.0) 56 (36.6) 0.09
 50–70 at 2 years (%) 2 (7.7) 42 (27.8)
 70≤ at 2 years (%) 11 (42.3) 55 (36.0)
Hospitalization
Duration of hospitalization, days 25.0 ± 11.4 22.8 ± 8.4 0.22
Duration of hospitalization ≥30 days (%) 6 (21.4) 26 (16.8) 0.55
Complications
All complications (%) 10 (35.7) 6 (3.8) <0.001
Infection (%) 3 (10.7) 1 (0.6) 0.012
Delirium (%) 7 (25.0) 3 (1.9) <0.001
Fall (%) 2 (7.1) 0 (0.0) 0.022
Other complications (%) 4 (14.3) 3 (1.9) 0.011
Implant failure (%) 2 (7.1) 0 (0.0) 0.022
Reoperation (%) 4 (14.3) 6 (3.8) 0.047
IQR: interquartile range, JOA: The Japanese Orthopedic Association, NRS: numerical rating scale, PD: Parkinson’s disease, 
SCS: spinal cord stimulation.
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Operative information: DBS vs. non-DBS groups
Operative characteristics for DBS and non-DBS 
groups are summarized in supplementary Table 2. 
There were no significant differences in the groups 
for any surgical procedure. The mean duration of 
anesthesia or operation time and the median blood 
loss also showed no significant differences between 
the groups.
Outcomes: DBS vs. non-DBS groups
The comparative data of outcomes in the DBS vs. 
non-DBS groups are summarized in Table 4. With 
respect to JOA score, the improvement rate was 
preserved at 2 years after the surgery (DBS group: 
40% vs. non-DBS group: 52%) as well as at 3 months 
(DBS group: 47% vs. non-DBS group: 40%) with no 
significant difference between the 2 groups. Regarding 
the NRS, the DBS group showed a significantly higher 
NRS score before surgery (10 vs. 7, p = 0.002). The 
improvement rate was preserved at 2 years after the 
surgery (DBS group: 75% vs. non-DBS group: 42%) 
as well as at 3 months (DBS group: 78% vs. non-DBS 
group: 71%) with no significant difference between 
the 2 groups. The mean duration of the 
Table 3 Characteristics of the DBS and non-DBS groups
Factor DBS group (n = 13) Non-DBS group (n = 15) p value
Age at spinal surgery, years 64.5 ± 7.9 71.6 ± 5.9 0.011
Age at spinal surgery over 75 (%) 4 (30.8) 12 (80.0) 0.009
Female sex (%) 8 (61.5) 7 (46.7) 0.43
Comorbidities
HT (%) 3 (23.1) 5 (33.3) 0.69
DM (%) 6 (46.2) 3 (20.0) 0.23
BMI, kg/m2 24.9 ± 3.0 24.4 ± 3.3 0.71
BMI ≥25 (%) 6 (46.2) 7 (46.7) 0.98
History of vertebral fracture (%) 5 (38.5) 1 (6.7) 0.069
History of hip joint surgery (%) 1 (7.7) 0 (0.0) 0.46
History of spinal surgery (%) 5 (38.5) 4 (26.7) 0.69
PTH administration (%) 4 (30.8) 0 (0.0) 0.035
History of SCS (%) 2 (15.4) 0 (0.0) 0.21
PD
Duration of PD, years 13.5 ± 2.9 7.7 ± 9.1 0.037
Hoehn and Yahr score (%)
 1 0 (0.0) 8 (53.3) <0.001
 2 0 (0.0) 2 (13.3)
 3 3 (23.1) 5 (33.3)
 4 10 (76.9) 0 (0.0)
 Over 3 (%) 13 (100.0) 5 (33.3) <0.001
Preoperative L-DOPA dose, mg 640 (IQR: 525–700) 200 (IQR: 100–375) <0.001
Lesion
Cervical (%) 3 (23.1) 6 (40.0) 0.44
Thoracic (%) 0 (0.0) 0 (0.0) -
Lumbar (%) 10 (76.9) 9 (60.0) 0.43
Symptoms
Limb pain (%) 9 (69.2) 8 (53.3) 0.46
Local pain (%) 10 (76.9) 8 (53.3) 0.25
Motor disability (%) 7 (53.8) 9 (60.0) 0.74
Numbness (%) 8 (61.5) 9 (60.0) 0.93
BMI: body mass index, DBS: deep brain stimulation, DM: diabetes mellitus, HT: hypertension, IQR: interquartile range, PD: 
Parkinson’s disease, PTH: parathyroid hormone, SCS: spinal cord stimulation.
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hospitalization also showed no significant difference 
between the groups (DBS group: 27 days vs. non-DBS 
group: 23 days). There were also no significant 
differences in terms of complications. In supplemen-
tary Table 3, the outcomes of lumbar lesions (n = 
19) in the DBS and non-DBS groups are compared. 
Similar to the data of all patients, the DBS group 
with lumbar lesions showed a significantly higher 
NRS score before surgery (10 vs. 8, p = 0.001). The 
complication rate of the DBS group with lumbar 
lesions tended to be smaller (30%) than that of the 
non-DBS group (66.7%, p = 0.17).
Table 4 Outcomes of the DBS and non-DBS groups
Factor DBS group (n = 13) Non-DBS group (n = 15) p value
JOA
JOA before surgery (IQR) 8 (4–10) 9 (6.5–12.5) 0.41
JOA after surgery (IQR) 18 (11–23) 20 (10–21) 0.64
JOA at 2 years (IQR) 18 (10.8–23.3) 17.5 (10–22) 0.72
JOA improvement rate after surgery, % (IQR) 46.7 (33.3–76.2) 40 (33.3–63.6) 0.7
 <30 after surgery (%) 1 (7.7) 3 (20.0) 0.47
 30–50 after surgery (%) 7 (53.9) 5 (33.3)
 50≤ after surgery (%) 5 (38.5) 7 (46.7)
JOA improvement rate at 2 years, % (IQR) 39.8 (25.8–81) 51.7 (18.1–61.9) 0.66
 <30 at 2 years (%) 3 (25.0) 4 (28.6) 0.51
 30–50 at 2 years (%) 4 (33.3) 2 (14.3)
 50≤ at 2 years (%) 5 (41.7) 8 (57.1)
NRS
NRS before surgery (IQR) 10 (9–10) 7 (5–8) 0.002
NRS after surgery (IQR) 2 (2–4) 2 (2–3) 0.67
NRS at 2 years (IQR) 2.5 (2.0–4.5) 3 (2–3.8) 0.96
NRS reduction rate after surgery, % (IQR) 77.8 (18.8–84.5) 71.4 (0–77.8) 0.36
 <50 after surgery (%) 4 (30.8) 6 (40.0) 0.88
 50–70 after surgery (%) 1 (7.7) 1 (6.7)
 70≤ after surgery (%) 8 (61.5) 8 (53.3)
NRS reduction rate at 2 years, % (IQR) 75.0 (10–80] 41.5 (0–78.1) 0.38
 <50 at 2 years (%) 5 (41.7) 8 (57.1) 0.19
 50–70 at 2 years (%) 0 (0.0) 2 (14.3)
 70≤ at 2 years (%) 7 (58.3) 4 (28.6)
Hospitalization
Duration of hospitalization, days 26.9 ± 11.5 23.4 ± 11.5 0.43
Duration of hospitalization ≥30 days (%) 5 (38.5) 1 (6.7) 0.069
Complications
All complications (%) 3 (23.1) 7 (46.7) 0.25
Infection (%) 1 (7.7) 2 (13.3) 1
Delirium (%) 2 (15.4) 5 (33.3) 0.4
Fall (%) 0 (0.0) 2 (13.3) 0.48
Other complications (%) 0 (0.0) 4 (26.7) 0.1
Implant failure (%) 1 (7.7) 1 (6.7) 1
Reoperation (%) 2 (15.4) 2 (13.3) 1
DBS: deep brain stimulation, IQR: interquartile range, JOA: The Japanese Orthopedic Association, NRS: numerical rating 
scale, PD: Parkinson’s disease.
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Spinal alignment: DBS vs. non-DBS groups
The data on spinal alignment of the DBS and 
non-DBS groups are shown in Table 5. LL measured 
at 2 years after spinal surgery in the DBS group (30 
degrees) was significantly larger than that in the 
non-DBS group (5 degrees). Similarly, PI-LL at 2 
years in the DBS group (27 degrees, p = 0.03) was 
significantly smaller than that in the non-DBS group 
(46 degrees). C7SVA at 2 years in the DBS group 
(130 mm, p = 0.12) was smaller than that in the 
non-DBS group (199 mm) although preoperative 
C7SVA of the DBS group (84 mm, p = 0.19) was 
smaller than that in the non-DBS group (134 mm). 
Thus, DBS might favorably affect spinal alignment 
for PD patients. Other than the parameters described 
earlier, there were no significant differences between 
the 2 groups in terms of Cobb angle, TK, PI, PT, or 
SS. In 19 patients with lumbar lesion, LL in the 
DBS group (28 degrees) was significantly larger than 
that in the non-DBS group (4 degrees).
Study 3: The subgroup analyses on lumbar 
degenerative disease patients with or without PD
Patient characteristics: PD vs. non-PD groups
There were significant differences between the 
PD (n = 19) and non-PD (n = 55) groups in history 
of hypertension (26% vs. 66%, p = 0.006), history 
of vertebral fracture (31% vs. 9%, p = 0.027), limb 
pain (74% vs. 93%, p = 0.04), lumbago (95% vs. 
67%, p = 0.03), motor disability (37% vs. 71%, 
p = 0.013), and numbness (42% vs. 73%, p = 0.025). 
For the PD group, the mean time after PD diagnosis 
at the initial surgery was 11.6 years. The Hoehn 
and Yahr score was stage 1 for 4 cases (21%), stage 
2 for 0, stage 3 for 8 (42%), stage 4 for 7 (37%), 
and stage 5 for 0. The median preoperative LEDD 
was 525 mg (range 300–688 mg). Ten cases (53%) 
had undergone previous DBS and 2 (11%) had 
undergone SCS. The information on SCS is described 
in Study 1 section.
Operative information: PD vs. non-PD groups
There were significant differences between the PD 
and non-PD groups in terms of the mean duration 
of anesthesia (441 vs. 328 min, p = 0.03), the mean 
duration of operation (343 vs. 234 min, p = 0.023), 
and median blood loss (200 vs. 50 ml, p = 0.002).
Outcomes: PD vs. non-PD groups
With respect to the JOA score, the improvement 
rate was preserved at 2 years after the surgery in 
56% of the PD patients vs. 75% of the non-PD 
patients (p = 0.035). Regarding the NRS score, 
Table 5 Spinal alignment before and at 2 years after surgery (DBS vs. non-DBS)
Factor DBS group (n = 13) Non-DBS group (n = 15) p value
C7SVA before surgery 83.6 (50.6) 133.5 (85.0) 0.19
C7SVA at 2 years 129.8 (69.0) 199.0 (24.6) 0.12
Cobb before surgery 18.0 (15.0) 15.7 (9.1) 0.80
Cobb at 2 years 17.0 (9.7) 15.3 (12.9) 0.81
TK before surgery 23.0 (13.9) 25.0 (10.8) 0.82
TK at 2 years 24.4 (14.4) 25.7 (11.0) 0.89
LL before surgery 28.5 (20.7) 24.0 (14.7) 0.73
LL at 2 years 30.3 (18.0) 5.0 (1.7) 0.04
PI before surgery 54.6 (13.0) 54.3 (2.3) 0.97
PI at 2 years 56.2 (9.7) 51.0 (6.6) 0.40
PI-LL before surgery 30.6 (17.7) 32.7 (15.5) 0.86
PI-LL at 2 years 27.1 (12.5) 46.0 (5.3) 0.03
PT before surgery 33.6 (11.9) 32.0 (6.2) 0.83
PT at 2 years 30.8 (11.5) 35.0 (6.2) 0.55
SS before surgery 20.9 (14.8) 22.3 (4.9) 0.88
SS at 2 years 25.3 (14.0) 16.0 (4.0) 0.29
All data are shown as mean (SD).
DBS: deep brain stimulation, C7SVA: C7 sagittal vertical axis (mm), Cobb: Cobb angle (degrees), LL: lumbar lordosis (T12-L5, 
degrees), PI: pelvic incidence (degrees), PT: pelvic tilt (degrees), SD: standard deviation, SS: sacral slope (degrees), TK: thoracic 
kyphosis (T5-T12, degrees).
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significant differences were observed in median 
NRS score before and at 2 years after surgery (PD 
group: 8 and 3 vs. non-PD group: 6 and 2, p = 0.015 
and p = 0.022, respectively). The NRS reduction 
rate of the PD group (78%) was significantly larger 
than that of the non-PD group (67%) after surgery 
(p = 0.027), although the difference was not found 
at 2 years after surgery (PD group: 73%, non-PD 
group: 85%, p = 0.13). Regarding complications, 
the overall complication rate was significantly 
higher in the PD group (47%), than in the non-PD 
group (5.5%, p <0.001). The PD group showed a 
 significantly higher rate of surgical site infection 
(15.8% vs. 1.8%, p = 0.05) and delirium (32% vs. 
1.8%, p = 0.001).
Patient characteristics: DBS vs. non-DBS groups
The DBS group (n = 10) showed a significantly 
younger mean age at the surgery (50 vs. 62 years) 
than the non-DBS group (n = 9, p = 0.018). The 
DBS group showed a significantly higher percentage 
of patients with Hoehn and Yahr scores ≥3 (100% 
vs. 56%, p = 0.002) and a higher preoperative LEDD 
(588 vs. 300 mg, p = 0.014).
Operative information: DBS vs. non-DBS groups
There were no significant differences between the 
groups for any surgical procedure and other oper-
ative parameters.
Outcomes: DBS vs. non-DBS groups
With respect to the JOA score, the improvement 
rate was preserved at 3 months (DBS group: 47% 
vs. non-DBS group: 40%), as well as at 2 years 
after the surgery (DBS group: 40% vs. non-DBS 
group: 52%) with no significant differences between 
the 2 groups. Regarding the NRS score, the DBS 
group showed a significantly higher NRS score 
before surgery (10 vs. 8, p = 0.001). The improve-
ment rate was preserved at 3 months (DBS group: 
78% vs. non-DBS group: 71%), as well as at 
2 years after the surgery (DBS group: 75% vs. 
non-DBS group: 42%) with no significant differ-
ences between the 2 groups. The mean duration 
of the hospitalization also showed no significant 
difference between the 2 groups (DBS group: 29 
days vs. non-DBS group: 26 days). There were 2 
cases with postoperative pneumonia, 1 case with 
urinary tract infection and 1 malnutrition case in 
the non-DBS group. The systemic complications 
were found only in the non-DBS group but not 
in the DBS group. STN DBS might ameliorate the 
systemic conditions with subsequent suppression 
of the perioperative complications after lumbar 
surgery.
Spinal alignment: DBS vs. non-DBS groups
LL measured at 2 years after lumbar surgery in 
the DBS group (27 degrees) was almost significantly 
larger than that in the non-DBS group (5 degrees, 
p = 0.052). Similarly, PI-LL at 2 years in the DBS 
group (29 degrees) was almost significantly smaller 
than that in the non-DBS group (46 degrees, p = 
0.064). C7SVA at 2 years in the DBS group (138 
mm) was smaller than that in the non-DBS group 
(199 mm, p = 0.17) although preoperative C7SVA 
of the DBS group (80 mm) was smaller than that 
in the non-DBS group (134 mm, p = 0.14). Thus, 
STN DBS might favorably affect spinal alignment 
for PD patients. Other than the parameters described 
earlier, there were no significant differences between 
the 2 groups.
Discussion
In this study, characteristics and outcomes after 
spinal surgery of PD patients with and without 
precedent STN DBS were explored. Before surgery, 
PD patients often suffered from pain due to lumbar 
lesions. The improvement of NRS in the PD group 
was greater than that in the non-PD group at 2 years 
after surgery, and PD patients receiving STN DBS 
preserved LL at 2 years after spinal surgeries. There 
were no significant differences in the DBS and 
non-DBS groups regarding functional recovery and 
pain reduction, although the severity of PD in the 
DBS group was significantly worse than that in the 
non-DBS group. STN DBS might favorably affect 
the results of spinal surgery for PD patients. By 
subgroup analyses on lumbar degenerative disease 
patients, the followings were shown. JOA score and 
improvement rate at 2 years in the non-PD group 
were significantly greater than those in the PD 
group. NRS score before surgery in the PD group 
was significantly greater than that in the non-PD 
group. NRS score reduction was greater in the PD 
group at 3 months after surgery, but not at 2 years 
after surgery. The complication rate was greater in 
the PD group. PD patients receiving DBS were more 
likely to preserve LL at 2 years after lumbar surgery 
(p = 0.052). There were no significant differences 
between the DBS and non-DBS groups regarding 
functional recovery and pain reduction, in spite of 
the worse PD severity in the DBS group with worse 
NRS score. Postoperative systemic complications 
including pneumonia, urinary tract infection, and 
hyponutrition were recognized only in the non-DBS 
group, but not in the DBS group (p = 0.033). Thus, 
STN DBS might favorably affect the results of lumbar 
surgery for PD patients.
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Previous reports on spinal surgery for PD patients
Previous studies reported a higher complication 
rate following spinal surgery for PD patients. It was 
reported that 86% of spinal surgeries for PD patients 
required 1 or more additional surgeries.9) In another 
study, the complication and revision surgery rates 
were 52% and 33%, respectively.4) A study of 96 
PD patients with spinal surgery showed that 21% 
of patients received revision surgeries and that a 
Hoehn and Yahr score over 3, diabetes mellitus, 
osteoporosis, and a combined anterior and posterior 
approach were risk factors for revision surgeries.10) 
The incidence of complications at an early stage 
after surgery, such as infection and ruptured wounds, 
was reported to be nearly 20%. Other reports also 
showed that PD patients have an increased risk of 
poor postoperative outcomes following spinal surgery 
compared to non-PD patients.4,9–16)A Hoehn and Yahr 
score over 3 in advanced PD patients was reported 
as a significant risk factor for requiring additional 
surgical intervention including revision surgeries.10,12,17) 
Severe PD patients with spinal diseases are not 
usually considered appropriate candidates for surgical 
intervention.10)
In our study, 10 cases (36%) experienced periop-
erative complications and 3 patients underwent 
reoperations (14%) although there were no reoper-
ations at 6 months after surgery. Our data are pref-
erable to the results of previous reports, largely 
because we preferred to choose less invasive surgeries 
for PD patients. For PD patients with lumbar spinal 
stenosis, we usually chose decompression surgery 
with a unilateral approach, which might minimize 
damage to the paraspinal, supra/interspinous muscles 
and preserve the facet joints with a subsequent 
reduction in postoperative iatrogenic instability. 
Postoperative delirium was reported to be more 
common in PD patients compared to the general 
population.18) Similarly, in this study, the rate of 
postoperative delirium of PD patients was almost 
8 times that of non-PD patients. It might therefore 
be important to control the perioperative compli-
cations after surgery for PD patients. The perioper-
ative management of a multidisciplinary team and 
the partnership between neurosurgeons and neurol-
ogists are essential for perioperative care, and early 
intervention against adverse events is desirable.14,19)
Neuromodulation and spinal surgery for 
PD patients
In our study, PD patients in the DBS group had 
a longer duration of PD at an advanced stage and 
an increased intake of L-DOPA. However, there were 
no significant differences in terms of surgery and 
outcomes after surgery, in spite of the preoperative 
worsened NRS. Advanced PD is thought to be a 
risk factor for spinal disease,10) so DBS might favor-
ably affect the outcomes. Interestingly, the LL of 
the DBS group was maintained at 2 years after 
spinal surgery compared to that of the non-DBS 
group. The maintenance of spinal alignment might 
contribute to pain control. In PD patients, chronic 
back pain is quite common.20) Painful sensations in 
PD patients are classified into several categories: 
musculoskeletal pain, neuritic or radicular pain, 
dystonia-associated pain, primary or central pain, 
and akathisia-like discomfort.21) DBS is reported to 
be effective for refractory low back pain in PD 
patients.22) Although the mechanism of pain relief 
brought about by DBS remains unclear, 3 possibil-
ities are considered: decreased muscle tonus, 
decreased sensitivity to pain/increased tolerance, 
and improved motor function.23) Regarding spinal 
malalignment, a treatment algorithm was presented 
for abnormal posture in PD patients.7) DBS and SCS 
are considered options for the treatment of some 
spinal deformities or postural abnormality associated 
with PD in selected patients.6,24,25) We believe that 
shortening the off-period by DBS might result in 
excellent long-term outcomes. In several papers on 
DBS for PD and spinal alignment,26–28) important 
data were revealed. DBS might be effective for spinal 
malalignment including camptocormia, although it 
is still controversial.26) Longer duration of campto-
cormia might lead to poor prognosis after DBS. In 
cases of DBS-ineffective camptocormia, spinal surgery 
might be the resolution. Long fusion surgery for PD 
patients with spinal malalignment might be favor-
able after DBS.27) In a review paper, it was described 
that preoperative optimization of motor control with 
medication and DBS might be needed for spinal 
surgery in PD patients.28) In our study, the preser-
vation of LL of PD patients with precedent STN 
DBS at 2 years after spinal surgery is first shown. 
The objective data on this issue might be critically 
important to think of spinal surgery for PD patients 
in the future.
Limitations of this study and unavoidable 
PD progression
There are several limitations to this study. First, 
since it is a retrospective study with a small sample 
size and heterogeneous spinal lesions, there is the 
natural possibility that it contains associated biases. 
Selection bias would not be excluded due to the 
difference of the indications for PD patients. As 
preoperative JOA and NRS scores showed, only the 
cases with severe impairment received spinal surgery 
in our study. We were able to limit long fusion 
surgeries to the minimum necessary. It has been 
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reported that long-range fixation to the pelvis might 
maintain LL with subsequent reduction of reoper-
ations.4,12) However, spinal deformities usually become 
exacerbated as PD progresses.29) The main cause of 
postural disorder lies in the PD pathology itself. 
Nowadays, biotechnology is rapidly advancing, but 
it is still difficult to completely maintain the spinal 
balance in accordance with the progression of PD 
through existing therapeutic options.30) It is important 
to evaluate the pathology for each PD patient and 
to determine the optimal treatment strategy by 
considering various treatment options.
Conclusion
In this study, we explored the characteristics, oper-
ative information, and outcomes after spinal surgery 
for PD patients and compared them with those for 
non-PD patients, with a particular focus on DBS. 
The pain relief persisted at 2 years after spinal 
surgery for PD patients, and precedent STN DBS 
maintained the spinal alignment with subsequent 
pain and functional amelioration at 2 years after 
surgery. By the subgroup analyses of lumbar degen-
erative disease patients, some significant differences 
were lost, but LL of patients with STN DBS was 
preserved at 2 years after surgery compared to that 
of patients without STN DBS (p = 0.052). Thus, the 
outcomes of spinal surgery for PD patients might 
be favorably affected by thorough treatment for PD 
including STN DBS.
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